Buy the Dip Monday: 4.8× Earnings, 49% Revenue Growth, and the Natural Gas Name with 14.8% Short Interest
Top 5 Pixie Picks
Only Pro and Free Trial readers get meta-analysis of the top 5 ranked Value stocks.
Sign in →6. GSK plc (GSK)
P/E: 13.1 | Earnings yield: 7.6% | 52w drawdown: -17.9%
GSK delivers a 19.9% ROIC, a 72.4% gross margin, and 4.1% revenue growth at a 13.1 P/E while trading 17.9% off peak and 13.8% below the $57.65 analyst consensus target. The company generates a 4.7% FCF yield and a 3.6% dividend yield, combining for a 1.4% shareholder yield after accounting for modest buyback activity, and the normalized 10-year P/E of 14.7 sits only 12% above the current trailing multiple, signaling the stock is pricing near historical valuation despite the margin and ROIC profile.
Insiders showed no net share activity over six months, with a 5.00 pipeline indicator but zero net shares transacted, and the 1.17 debt-to-equity ratio is the second-highest on the screen after BANC. The 19.06× EV/EBITDA multiple is the most expensive among all eight names, reflecting the market's willingness to pay for pharma durability but leaving limited re-rating upside if growth does not re-accelerate from the 4.1% year-over-year pace.
Short interest is only 0.4% of float, the lowest on the screen, which removes the short-squeeze catalyst but also signals consensus positioning is already long, meaning upside depends on fundamental delivery rather than technical squeeze dynamics.
7. MPLX LP (MPLX)
P/E: 11.6 | Earnings yield: 8.6% | 52w drawdown: -10.6%
MPLX trades at 11.6× earnings and 3.81× book while generating an 8.6% earnings yield, an 8.0% distribution yield, and a 19.7% ROIC with a 43.6% gross margin. The company grew revenue 5.2% year-over-year and sits 10.6% off peak, the second-shallowest drawdown on the screen, with a normalized 10-year P/E of 12.9 only 11% above the current trailing multiple, signaling the partnership is priced near historical midpoint valuation despite the ROIC and distribution profile.
Three insiders filed Form 4 activity in early May: Stice J Michael, Surma John P, and Breves Christine S (all period ending May 4), though six-month net share activity is zero with a 5.00 pipeline indicator. The distribution yield of 8.0% is the highest on the screen and creates a 7.3% shareholder yield when combined with modest buyback activity.
The 13.21× EV/EBITDA multiple is elevated relative to midstream peers, and Q1 earnings missed estimates on higher costs and expenses, flagging margin pressure that could compress the setup if operating leverage does not improve in the back half of 2026.
8. Newmont Corporation (NEM)
P/E: 15.6 | Earnings yield: 6.4% | 52w drawdown: -10.7%
NEM delivers a 29.9% ROIC, a 53.2% gross margin, and 21.3% revenue growth at a 15.6 P/E while trading 10.7% off peak and 19.5% below the $144 analyst consensus target. The company generates a 5.7% FCF yield and a 0.9% dividend yield, combining for a 1.8% shareholder yield, and the 0.16 debt-to-equity ratio is the second-lowest on the screen after FSLR, leaving balance-sheet flexibility for M&A or incremental capital return.
Insiders showed minimal net activity over six months, with only 3,502 shares sold net and a 2.2% buy ratio versus 2.3% sell activity, signaling neutral insider conviction despite the ROIC and margin profile. The normalized 10-year earnings yield of 2.0% sits meaningfully below the current 6.4%, indicating the market is paying for cyclical peak earnings at a premium to long-cycle normalized power.
The 7.42× EV/EBITDA multiple and 3.70× book value are elevated relative to diversified miners, and the 1.8% short interest is the second-lowest on the screen, removing the short-squeeze catalyst while leaving the setup dependent on gold price continuation rather than valuation re-rating or operational surprise.
What to Watch
- EQT Q2 earnings (late July): Revenue growth trajectory after the 60% year-over-year Q1 print will clarify whether the operational leverage to gas prices is structural or transient, and any guidance update on capital allocation or buyback pace matters for the 8.1% FCF yield setup.
- FSLR U.S. manufacturing capacity updates (June): Any announcements around Georgia or Louisiana module production ramps or tariff exemption clarity will move the 19.3% drawdown entry if utilization or pricing expectations reset higher.
- AMAL AI crime tool deployment timeline (Q2/Q3): The FIS-Anthropic partnership pilot is a margin and efficiency catalyst if the bank announces a production rollout schedule or cost-save quantification, particularly against the $40 billion AML false-positive benchmark cited in May news.
- CNX and Newmont commodity price sensitivity (ongoing): Natural gas strip pricing and spot gold levels are the primary valuation levers for the 4.8 P/E and 15.6 P/E setups, respectively; any macro shift in energy or metals expectations will reset analyst targets and the drawdown entry points.
Go Deeper
The value screener surfaces stocks trading at single-digit P/Es or double-digit earnings yields with operational momentum, insider accumulation, and balance-sheet durability.
Pro-only analytics
Named tickers from this article open in the app with Pro or an active trial.
Sign in →Stock Pixie Pro
See the full Buy the Dip screen — every pick, every metric, every day.
The app shows up to 10 rows on Free; the top 5 by Pixie rank keep ticker, name, and recent close private. Posts may name the top 5 for context. Pro and trial show every row on the screener, full identifiers, and the rest of Pro.
Start your free trial →